PMC:7712180 / 81401-81770
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2845 | 296-298 | Gene | denotes | α2 | Gene:170589 |
2846 | 252-254 | Gene | denotes | α2 | Gene:170589 |
2854 | 25-33 | Species | denotes | MERS-CoV | Tax:1335626 |
2855 | 135-144 | Species | denotes | dromedary | Tax:9838 |
2856 | 145-150 | Species | denotes | camel | Tax:9838 |
2857 | 175-180 | Species | denotes | human | Tax:9606 |
2858 | 325-336 | Species | denotes | pipistrelle | Tax:59474 |
2873 | 98-107 | Disease | denotes | infection | MESH:D007239 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T430 | 0-369 | Sentence | denotes | Accordingly, multivalent MERS-CoV S1A-containing nanoparticles were shown to specifically bind to infection sites in individual hosts: dromedary camel nasal epithelial cells, human type II pneumocytes in the alveolar wall that contains an abundance of α2,3-sialyl type 2 LN and a small amount of α2,3-sialyl-LewisX [19], and pipistrelle bat intestinal epithelial cells. |